Gabriella Pridjian
Maternal & Fetal Medicine · New Orleans, LANPI 1699868471
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,710 of the $2,339 with a category attached, or 73.1%. Biomarin Pharmaceutical Inc. accounts for 73.1% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $1,844 and has fallen 93.1% since, to $128 in 2025. Among maternal & fetal medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $68.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$2K
- AbbVie$57
- Aspira Women's Health Inc$55
- Dexcom, Inc.$52
- Roche Diagnostics Corporation$50
- Organon$39
- plus $376 from 18 others
What the payments were for
- Speaking & faculty fees$1,71073%
- Food & beverage$62927%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 1 | $1,710 |
| AbbVie | 4 | $57 |
| Aspira Women's Health Inc | 1 | $55 |
| Dexcom, Inc. | 1 | $52 |
| Roche Diagnostics Corporation | 3 | $50 |
| Organon | 3 | $39 |
| Johnson & Johnson | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Boston Scientific | 1 | $31 |
| Dilon Technologies, Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Merck | 2 | $30 |
| American Regent | 1 | $28 |
| Pfizer | 1 | $20 |
| Convatec Inc. | 1 | $18 |
| Urovant Sciences Inc | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Vertex | 1 | $15 |
| Bayer | 1 | $12 |
| Coopersurgical, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $11 |
| Agile Therapeutics, Inc. | 1 | $11 |
| Therapeuticsmd, Inc. | 1 | $11 |
How this compares
$2,339 in reported general payments places this provider in the 95th percentile of 27 maternal & fetal medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nifedipine ErNifedipine | 14 | $108 |
| Estradiol | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Other maternal & fetal medicine in New Orleans
- Paul ClishamNew Orleans$1K
- Joseph BiggioNew Orleans$791
- Robert MaupinNew Orleans$594
- Barbara NeuhoffNew Orleans$234
- Cecilia GambalaNew Orleans$198
- Jane MartinNew Orleans$182
- Joseph MillerNew Orleans$124
- Asha HeardNew Orleans$78
- Frank WilliamsNew Orleans$72
- Sherri LongoNew Orleans$72
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.